Optimizing Cell
Therapies for
|
The only predictive platform for tumor infiltration.
Technology access program for qualified projects
Accelerate your cell therapy development with priority access to our adhesion biomarker platform. Get comprehensive analysis and expert consultation for your pilot study.
Learn More
The breakthrough
you need.
Our applications.
Real-world applications of our platform demonstrate significant improvements in cell therapy development and manufacturing outcomes.
Screen and optimize cell therapy candidates using adhesion biomarkers for more efficient development
Optimize cell manufacturing using quantitative adhesion biomarkers for better product characteristics
Identify adhesion biomarkers that predict tumor infiltration for patient response and potency
Our platform.
From discovery to clinical biomarkers.
We solve for a critical challenge in solid tumor cell therapies: predicting which immune cells can successfully navigate to cancer sites. Through advanced adhesion chromatography that models tumor vasculature, we identify therapeutic candidates with the highest infiltration potential.
Learn more
Where precision meets possibility.
We predict which immune cells will successfully infiltrate and target solid tumors, giving researchers the confidence to advance therapies that can improve outcomes. From lab to clinical research, we're accelerating progress toward better treatments. Transforming immune therapies, one breakthrough at a time.
Such systems could be applied for sorting specific functional phenotypes of T cells, such as T cell subtypes with superior homing and infiltration potential. Importantly, sorting requires high-throughput operation and scalability to ensure appropriate yield for treatment purposes.
Stay updated on
our progress.
Get the latest news on our research breakthroughs, partnerships, and platform developments.
Deep science, real breakthroughs.